baber/WOPTO huggingface dataset:
Patent IE-39481-L (IE)
Title: Imidazoline derivatives.
IPC: C07D233/20
Filed: 1974-02-22
Abstract: 1455624 2 - Phenylaminoimidazolines - (2) BOEHRINGER INGELHEIM GmbH 22 Feb 1974 [23 Feb 1973] 8202/74 Heading C2C Novel 2 - phenylaminoimidazolines - (2) of the general formula wherein each of R 1 , R 2 and R 3 is a hydrogen, fluorine, chlorine or bromine atom or a methyl, ethyl, methoxy, trifluoromethyl or cyano group and each of R 4 and R 5 , which must be different, is a hydrogen atom or a group of formula in which R 6 is a hydrogen atom or a methyl or ethyl group, with the proviso that one of R 4 and R 5 is a hydrogen atom, and acid addition salts thereof are prepared (a) when R 5 is a hydrogen atom, by reacting the corresponding compound in which R 4 is a hydrogen atom with a compound of the general formula wherein Hal is a chlorine, bromine or iodine atom; (b) when R 5 is a hydrogen atom, by reacting a compound of the general formula wherein A is a cyano or -C(=NH)Y group, in which Y is an atom or group removable as an anion, with ethylene diamine or an acid addition salt thereof; (c) when R 4 is a hydrogen atom, by reacting a compound of the general formula wherein X is as Y above, with a compound of the general formula and (d) by reacting a compound of the general formula wherein M is a metal and n represents the charge on the cation, with a compound of the second general formula above; and, if desired, converting a resulting free base into an acid addition salt thereof. Pharmaceutical compositions having analgesic and blood pressure-reducing activity comprise, as active ingredient, at least one 2-phenylaminoimidazoline-(2) or physiologically compatible acid addition salt thereof, in association with a pharmaceutical carrier or excipient.
[GB1455624A]
Patent IE-890523-L (IE)
Title: Antihypercholesterolemic tetrazoles
IPC: C07C69/675
Filed: 1989-02-17
Abstract: This invention provides novel intermediates of the formula <IMAGE> in substantially the cis or cis-(4R,6S) form wherein R9 and R10 each are C1-4alkyl or R9 and R10, taken together with the carbon atom to which they are attached, is cyclopentyl, cyclohexyl or cycloheptyl; and R12 is hydrogen, C1-4alkyl or a metal cation and processes thereof which are useful for the preparation of antihypercholesterolemic agents.
[US4824959A]
Patent IE-830608-L (IE)
Title: Quinolinone derivatives
IPC: C07D215/58
Filed: 1983-03-21
Abstract: Novel 1-R-1,4-dihydro-4-oxo-6-fluoro-7-(Z=N-)-quinolinecarboxylic acids and esters thereof, where R is amino, lower-alkylamino, 2-propenylamino or di-lower-alkylamino, R'' is hydrogen or lower-alkyl, and Z=N is a heterocyclic group, useful as antibacterial agents, are prepared by reacting the corresponding 7-chloroquinoline derivatives with the appropriate heterocyclic compound, Z=NH. A preferred group of compounds are those where Z=N is 1-piperazinyl or 4-lower-alkyl-1-piperazinyl.
[US4499091A]
Patent IE-830692-L (IE)
Title: Plasmid cloning vector for bacillus subtilis
IPC: C12N15/09
Filed: 1983-03-28
Abstract: A novel chemical compound, plasmid pOS4, is prepared by joining fragments of the plasmids pSE3 and pE194. The pOS4 plasmid, containing kanamycin resistance and erythromycin resistance coding genes, is useful as a cloning vehicle in recombinant DNA work.
[US4419450A]
Patent IE-820756-L (IE)
Title: Manufacture of mineral fiber mat
IPC: D04H1/4209
Filed: 1982-03-30
Abstract: 1. Process for the manufacture of webs of mineral fibres, in which - fibres are produced and then carried by gas currents to a receiving device (3) where they are collected and separated from the carrier gas, - a finely dispersed liquid binder composition is projected into the gas current carrying the fibres, upstream of the receiving device (3), - the web of fibres (6) is optionally treated, in particular heat treated, to fix the binder, and subjected to transformations leading to its final form, - water is sprayed into the path of the gas which has carried the fibres, downstream of the receiving device, and/or that of the gas emanating from the treatment operations for fixing the binder and/or the transformation of the mat of fibres (6), characterised in that the water is dispersed by the collision of jets directed towards one another so that a sheet of dispersed water forms transversely to the path of the gas.
[EP0062586A1]
Patent IE-870781-L (IE)
Title: Laboratory crucible.
IPC: C22C21/00
Filed: 1987-03-26
Abstract: A crucible for the thermal analysis of aluminum alloys is disclosed. This crucible is charaterized in that the internal surface of at least one of its side walls is at least partially covered with a film of refining agent. The crucible finds application in measuring both the silicon content in and the degree of refining of hypereutectic aluminum-silicon alloys.
Patent IE-810836-L (IE)
Title: Washing machine
IPC: D06F33/02
Filed: 1981-04-13
Abstract: A method of washing textile articles in which, whilst the articles are immersed in a washing liquid, the liquid is heated to a low temperature in the region of 30 DEG C and is agitated for brief periods in the region of 15 to 60 seconds by reversals of a drum rotatable about a substantially horizontal axis and containing the liquid and articles in each of a succession of longer basic periods in the region of 5 to 20 minutes, all continuing over a period of 2 hours or longer. Preferably increments of rotation are of different amounts in opposite directions respectively. A machine having a control means determining the temperature of the liquid and the durations of the basic periods and periods of agitation is also provided. <IMAGE>
[GB2074612A]
Patent IE-810850-L (IE)
Title: Rock drill
IPC: E21B17/22
Filed: 1981-04-14
Abstract: A rock drill is formed of an axially elongated member made up of a cutting bit at one end followed by a helically grooved shaft and then ending in a shank. At least a portion of the groove, viewed in the axial direction of the member, has a stepped bottom providing groove sections of different depths. The depth of the groove sections from the surface of the shaft decreases in the direction toward the shank.
[US4458769A]
Patent IE-790903-L (IE)
Title: Flameproof polypropylene fibre
IPC: C08L23/10
Filed: 1979-08-08
Abstract: 1. Polypropylene fibre which is difficult to ignite and has an ethylene content of 0 to at most 10% by weight, characterised in that it contains 0.5 to 10% by weight of 1,3,5-tris-(2,3-dibromopropyl)-2,4,6-trioxo- hexahydrotriazine and 0.15 to 3.5% by weitht of Sb2 O3 , and per mol of the triazine compounds 0.05 to 1.5 mols of an organic tin compound of the general formula see diagramm : EP0005496,P6,F1 in which R1 and R2 , which can be identical or different, each denote an alkyl or cycloalkyl radical and X and Y, which can be identical or different, each denote an alkyl or cycloalkyl radical, the radical of an organic acid, which can optionally contain a further esterified carboxyl group, the radical of an inorganic acid or a thioalkyl group, which can optionally carry a carboxyl group esterified with aliphatic alcohols, or X and Y together denote oxygen, the radical of a dibasic inorganic or organic acid or a radical of the formula -S-(CH2 )n -COO- in which n is defined as the integer 1 or 2, if appropriate in addition to the customary lubricants, pigments and/or stabilisers.
[EP0005496A1]
Patent IE-880977-L (IE)
Title: Nitroethane derivatives
IPC: C07D277/28
Filed: 1988-03-31
Abstract: The novel process for the preparation of the nitroethene derivatives ranitidine and nizatidine proceeds via novel intermediates and makes it possible to prepare the compounds mentioned in higher purity. A further advantage is that, in contrast to the known processes, no methane thiol is liberated, which is highly toxic and malodorous. 
[EP0285681A1]
Patent IE-800991-L (IE)
Title: HBs Ag GENE AND PRODUCT
IPC: C12N15/00
Filed: 1980-05-14
Abstract: DNA transfer vector comprising the genome of a non-passageable virus. The vector can be a plasmid and the virus hepatitis B virus. The production of antigenic protein by the expression of the recombinant DNA in a host cell. The enhancing of the antigenicity and the stability of the antigenic protein by chemical modification.
[EP0020251A2]
Patent FI-810465-L (FI)
Inventor: CHAPPOT ALAIN
IPC: B42F17/00
Filed: 1981-02-16
Abstract: A guide unit (9) for the flat objects, the unit includes a plurality of guide paths (12,15,16) and movable along one side of a magazine for holding flexible flat objects transversely to the one side in locations spaced along the one side of the magazine, it being thus possible to place a first such guide path (12) opposite a first such location (6), the other guide paths of the guide unit, which diverge away from the first guide path being placed simultaneously opposite the locations (5,7) adjacent the first location. An ejection device (10) moves any flat objects (8) contained in the neighbouring locations (5,7) outward from the one side of the magazine into the divergent paths (15,16) of the guide unit to provide a clear opening before an object is inserted in the first location.
Patent FI-810932-L (FI)
Inventor: INDEHERBERGH JEAN
IPC: C25B13/04
Filed: 1981-03-26
Abstract: Permeable diaphragm for a cell for the electrolysis of aqueous solutions of an alkali metal halide, the diaphragm being made from a hydrophobic organic polymeric material containing an oxide of a metal chosen from amongst group IIa of the periodic table of the elements, the oxide being in the form of particles having a mean diameter of at most 0.5  mu m.
Patent FI-850343-L (FI)
Inventor: PIETZSCH KURT E
IPC: B01D33/333
Filed: 1985-01-25
Abstract: Vacuum filter for the separation of solids from liquids with a conveyor (12) rotating around wheels (4, 14) arranged in longitudinal distance of each other, on which conveyor there is movably fixed an endless row of trays (1) forming a horizontal filter area, which trays (1) are led over a stationary vacuum channel (16). 
<??>In order to make the filter cloth capable of being cleaned if the filter is in operation and in order to provide a simple maintenance and repair, according to the invention it is provided, that an endless filter cloth (19) is been put onto the trays (1) above the filtration zone, that the washing devices (35) for this area are foreseen outside the filtration zone, that each tray (1) has a sealing (5, 6) in the direction of course in the front and the back, and that it is built without fringe such, that the row of adjoining trays (1) above the filtration zone form a common filter area (7) and that all trays (1) are connected to an elastic endless belt (9), which is connected to and led over the vacuum channel (16) in a gliding way going over holes for the drainage of the filtrate.
Patent IE-801055-L (IE)
Title: Electrical distribution board
IPC: H02B1/16
Filed: 1980-05-21
Abstract: An electric distribution board serves for the distribution of two phases, or of two phases and an earth and has a back member which receives, according to choice, two mounts which are each appropriate to the respective method of current distribution, these mounts comprising selector means which only permit couplings with compatible current connector plugs.
[US4477131A]
Patent IE-32495-L (IE)
Title: Sulphonamides
IPC: A61K31/505
Filed: 1968-11-19
Abstract: 1,254,720. Hypoglyceamic compositions comprising sulphonamides. SCHERING A.G. 20 Dec., 1968 [30 Dec., 1967], No. 60767/68. Heading A5B. [Also in Division C2] Pharmaceutical preparations, having the effect of lowering blood sugar, comprise as active ingredient compounds I (including salts thereof), wherein X and W signify O, S or a direct bond, Y is alkylene, R, R' and R" signify H, halogen, alkyl, alkoxy, alkenyloxy, benzyloxy, C 5 or 6 cycloalkyl, alkylmercapto, alkylsulphinyl, alkylsulphonyl, phenyl, acyloxy, acyl, benzoyloxy, benzoyl, CF 3 , CN, NO 2 , acylamino or carbamoyl, Z is H or alkyl, R"' is a C 1 to 8 hydrocarbon group which may be cyclic and/or may be interrupted by one or more oxygen atoms, or is a phenyl group that is substituted by one or more halogen atoms, alkoxy groups and alkylmercapto groups, and A signifies a monocyclic or bicyclic aryl group, a heterocyclic group or an araliphatic group. The usual forms for oral administration are described. Among the bases specified for salt formation are butyl-biguamide, methylglucamine, morpholine and ethanolamine.
[GB1254720A]
Patent IE-39990-L (IE)
Title: Printed sheet material
IPC: B29C48/08
Filed: 1974-07-23
Abstract: 1467362 Laminates VAN DAALEN PATENTS NV 15 July 1974 [23 July 1973] 31188/74 Headings B5N and B5A A method of making sheet synthetic material, one face of which is printed, comprises the steps of forming by co-extrusion a laminate comprising a first layer of unused plastics material and a second layer of waste material of the same kind and bonding a printed foil to the layer of waste material, the printed foil being of the same materials as the layers. The plastics material may be of polystyrene. The sheet may be deep drawn to form a shaped article, e.g. a cup.
[GB1467362A]
Patent IE-45321-L (IE)
Title: Sprayable germicidal foam compositions
IPC: A61K9/12
Filed: 1977-07-27
Abstract: OF INVENTION A sprayable germicidal foam composition containing a therapeutically sufficient quantity of the microbicidally active agent; an aliphatic fatty alcohol and an aliphatic fatty acid, each agent being in critical ratio to each other, in parts by weight of from 1:2 with a preferred range for this critical ratio of from 0.5 parts to 2.0 parts by weight of the fatty alcohol, to 1 to 3 parts by weight of the fatty acid; a nonionic surface tension reducing agent in concentration of at least equal to one-half of the combined weight of the fatty alcohol and fatty acid moieties but not greater than three times the weight of the fattyalcohol present; and aqueous-aliphatic glycol mixture, in critical proportion offrom 1 part aliphatic glycol to 15 parts of water, with a preferred range of critical ratio of from 0.5 to 1.5 parts by weight of said glycol, to 7.5 parts to 30 parts by weight of water, and a suitable aerosol propellant, in sufficient quantity to provide a ratio of from 0.5 parts to 3 parts by weight of said propellant to 7 to 9.5 parts by weight of sprayable composition, the whole being packaged in a pressurized container fitted with a release valve. When the container pressure is released, a durable foam is extruded to provide a safe and effective, pain-free, germicidal barrier to burned, abraded or wounded skin and mucous membranes of humans and animals, when applied form 1 to 6 times daily.
[CA1095410A]
Patent IE-801641-L (IE)
Title: Vehicle speed control apparatus
IPC: B65G1/06
Filed: 1980-08-06
Abstract: Automatic braking apparatus for controlling the speed of a vehicle travelling downwardly on an inclined slope. The apparatus comprises a wheel housing, a pair of specially designed wheels mounted in the housing for combined rotary and axial motion, and a rail engageable between the wheels and moveable longitudinally relative thereto. The wheels have tapered camming surfaces which confront one another and annular braking surfaces facing outwardly in juxtaposition with respect to pads of friction material carried by the housing. A load applied between the rail and the wheels forces the wheels axially outward into engagement with the friction pads to retard rotation of the wheels and thereby to limit the relative velocity between the rail and the wheel housing. In one embodiment, the wheel housing is carried by a pallet and the rail is mounted stationary. Wedge means is provided at the lower end of the rail for engaging between the wheels relatively close to their rotational axis to arrest motion of the pallet. In another embodiment, the wheel housing mounts a plurality of the special wheels, and the rail depends from the pallet and engages between the wheels. In this embodiment, motion of the pallet is arrested by causing the rail to enter a zone where the wheels are spaced further apart. Other embodiments are also disclosed.
[US4234069A]
Patent IE-42605-L (IE)
Title: Rifamycins.
IPC: C07D498/08
Filed: 1975-08-11
Abstract: 1470426 Rifamycins GRUPPO LEPETIT SpA 20 Aug 1975 [30 Aug 1974] 37913/74 Headings C2A and C2C A process for producing rifamycin P, rifamycin Q, rifamycin R and rifamycin U comprises cultivating a mutant Nocardia mediterranea strain selected from Nocardia mediterranea ATCC 31064, Nocardia mediterranea ATCC 31065 and Nocardia mediterranea ATCC 31066 and mutants and equivalents thereof under aerobic conditions in a nutrient medium containing an assimilable carbon source, an assimilable nitrogen source and essential mineral salts until substantial antibiotic activity is present and recovering the rifamycins. The rifamycins may be recovered by extracting the fermentation broth with a water-immiscible solvent at a pH lower than 5. The rifamycins may be separated by column chromatography. The new mutants may be prepared by treating a suspension of spores of Streptomyces mediterranei ATCC 13685 with a mutagenic agent, incubating the treated spores and isolating the surviving colonies which are able to inhibit the growth of Bacillus subtilis Rifamycin P has the following characteristics:- (1) Elemental analysis (per cent) C = 60À6, H= 6À2, N=3À8, O=25À2, S=4À1, (2) U.V. spectrum indicated in Fig. 1 (not shown), (3) I.R. spectrum indicated in Fig. 2 (not shown), (4) A mass spectrum at 70 eV showing the M<SP>+</SP> peak at the m/e value of 738, (5) N.M.R. spectrum indicated in Fig. 3 (not shown) and (6) Rf value of 0À57. Rifamycin R has the formula Rifamycin Q has the following characteristics (1) Elemental analysis (per cent) C=60À7, H= 6À3, N=3À6, O=25À3, S=4À2, (2) U.V. and visible absorption bands:- # max. (mÁ) E 1% 1 cm. 406 178 350 (shoulder) 297 305 257 405 224 518 (3) I.R. spectrum indicated in Fig. 4 (not shown), (4) N.M.R. spectrum indicated in Fig. 7 (not shown) and (5) Rf value of 0À32. Rifamycin U has the following characteristics (1) U.V. and visible absorption bands:- # max. (mÁ E 1% 1 cm. 412 163 353 (shoulder) 299 265 258 389 220 451 (2) the most significant absorption peaks in Nujol occur at the following frequencies (cm.<SP>-1</SP>): 3700-3100 (m, br); 3060 (vw); 3040-2740 (vs), 2720 (vw), 1460 (s), 1378 (m); Nujol; 1750-1705 (m, br) ; 1680-1620 (m, br) ; 1600 (s); 1558 (s); 1490 (w, shoulder); 1308 (w) ; 1270 (w, shoulder); 1245 (m, shoulder); 1225 (m); 1160(m); 1120(w); 1090(vw); 1070 (w); 1030 (vw); 1020 (vw); 1000 (vw); 975 (w); 960 (w, shoulder); 905 (m); 850 (m) ; 802 (w) ; 800 (vw, shoulder); 777 (vw); 760 (vw); 720 (vw); 685 (vw); 670 (vw) and (3) Rf value of 0À63.
[GB1470426A]
Patent IE-41841-L (IE)
Title: 3-quinoline carboxylic acid amides
IPC: C07D215/12
Filed: 1975-08-12
Abstract: Novel 3-quinoline-carboxamides of the formula WHEREIN R is selected from the group consisting of halogen, -CF3, -OCF3 and -SCF3 in the 7- or 8-position, R1 is selected from the group consisting of hydrogen and acyl of an aliphatic carboxylic acid of 2 to 4 carbon atoms, R3 is selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms and R2 is selected from the group consisting of thiazloyl, pyridinyl and oxazolyl and their non-toxic, pharmaceutically acceptable acid addition salts having analgesic activity and their preparation and novel intermediates.
[US3992540A]
Patent IE-44161-L (IE)
Title: Prostaglandin analogues
IPC: A61K31/19
Filed: 1976-08-17
Abstract: The present invention relates to compounds of the formula:  VII wherein A represents a grouping of the formula:  VIIIA  VIIIB  IV B represents an oxygen or sulphur atom, R1 and R2, which may be the same or different, each represent a hydrogen or halogen atom, a trifluoromethyl group, or a straight- or branched-chain alkyl or alkoxy group containing from 1 to 4 carbon atoms, R represents a group of the formula -COOR3, in which R3 represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 12 carbon atoms, or a group of the formula -CH2OR4, in which R4 represents a hydrogen atom or an alkylcarbonyl group containing from 2 to 5 carbon atoms and the double bonds depicted in positions C2-C3, C5-C6 and C13-C14 are trans, cis and trans respectively, the cyclodextrin clathrates thereof and, when R3 in the group -COOR3 represents a hydrogen atom, non-toxic salts thereof. These compounds exhibit characteristics of prostaglandin-like activity. (From US4065632 A) [FR2321277A1]
Patent IE-892317-L (IE)
Title: Fatty acid composition
IPC: A61P1/04
Filed: 1989-07-18
Abstract: Fatty acid composition comprising at least 80% by weight of omega-3-fatty acids, salts or derivatives thereof, wherein (all-Z)-5,8,11,14,17-eicosapentaenoic acid (EPA) and (all-Z)-4,7,10,13,16,19-docosahexaenoic acid comprises at least 75% by weight of the total fatty acids. The compositions can be used for the treatment or prophylaxis of multiple risk factors for cardiovascular diseases.
Patent IE-40117-L (IE)
Title: Spraying apparatus
IPC: B05B14/00
Filed: 1974-11-13
Abstract: 1446841 Spraying apparatus B P B INDUSTRIES Ltd 13 Nov 1974 [16 Nov 1973] 53348/73 Heading B2L [Also in Division Dl] Apparatus for spraying sheets or a web includes a screen 8 movable at the dictates of a sensor 16 sensing the speed of the sheet or web. The spray from nozzles 1 is interrupted by the movable screen 8, material being returned to a reservoir 6. Sensor 16 detects the speed of the article 2 to be coated, and adjusts the screen position so that the amount of spray material per unit area is constant. A cam arrangement 19 compensates for the non- uniformity of the spray pattern. If the nozzles are horizontal the screen may be vertical and include a gutter. Both sides of the article may be coated by diverting the article and appropriate positioning of the nozzles and screens.
[GB1446841A]
Patent IE-792418-L (IE)
Title: Diazines.
IPC: C07D237/26
Filed: 1979-12-13
Abstract: 2-Aryl-3,4-diaza-bicyclo-[4.1.0]hept-2-en-5-ones, substituted in the phenyl ring, of the general formula   <IMAGE>   their preparation, and therapeutic agents, containing these compounds, which may be used for the treatment of hypertension or of thrombo-embolic disorders.
Patent IE-832535-L (IE)
Title: Process for making bismuth-containing pyrochlores
IPC: H01B1/06
Filed: 1983-10-28
Abstract: Method for making a pyrochlore of the formula Bi2-xMxB2O7-z by firing finely divided particles of bismuth oxycarbonate. The pyrochlores made by the invention have a high surface area and are especially useful as the conductive phase for thick film resistors.
[US4420422A]
Patent IE-41960-L (IE)
Title: Cloth-like tissue laminates
IPC: D06M17/00
Filed: 1975-12-02
Abstract: Improved tissue, continuous filament nonwoven laminates which are characterized by relatively high strength or toughness, relatively high loft and drape together with low noise or paper-like rattle. The improved tissue, continuous filament nonwoven laminates, while exhibiting a relatively high strength, are comprised of a low tensile strength, low basis weight, lightly bonded or unbonded layer of continuous filament nonwoven which is impregnated with about 50% to about 120%, based on the continuous filament nonwoven layer basis weight, of soft, tacky latex solids. The impregnated continuous filament nonwoven is combined under minimum combining pressures, while in the impregnated moist state between at least two, soft absorbent tissue facing layers prior to drying the laminate and curing the latex solids.[US4113911A]
Patent IE-44195-L (IE)
Title: Wire support insulator
IPC: H01B17/14
Filed: 1976-12-20
Abstract: 1530390 Wire supporting insulator AHI OPERATIONS Ltd 14 Dec 1976 [7 Jan 1976] 52113/76 Heading H2C An insulator for supporting a wire, e.g. of an electric fence comprises a body member 1 of insulating material fastenable to a support, e.g. by a nail 10 or a bolt, a groove 3 in the upper surface of the body to receive the wire and a pivoted cover 7 having a slot which can be snap fitted on to a pin on the body member so that the wire is held in its groove. The body and cover may be of polyethylene or polypropylene. Shaped rain deflecting portions 15 are moulded at either end of the body. In Fig. 3, not shown, the body has a bifurcated portion mountable on a post by means of a pin.
[GB1530390A]